Back to News
Oct 24, 2025 12:00 PM

Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark

Sanofi SA (NASDAQ:SNY) reported third-quarter sales of $14.55 billion (12.43 billion euros), beating the consensus of $14.46 billion. Sales increased 2.3% year over year, up 7% in constant currency.

U.S. sales were 6.84 billion euros, up 11.1%, primarily driven by Immunology, pharma launches, and Lantus, partly offset by vaccines.

Pharma increased sales by 57.1% to 1 billion euros, driven by ALTUVIIIO and Ayvakit.

The French drug maker reported third-quarter business operating income of 4.45 billion euros, up 8.5% year over year and 2.7% in constant currency.

The reported adjusted EPS of 2.91 euros or $1.70 per ADS, ...